Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01)

The summary for the Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01): -Purpose. This Funding Opportunity Announcement (FOA) issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), solicits grant applications from institutions/organizations that propose to exploit present knowledge of Ca2+ regulatory molecules and the role they play in arrhythmogenesis to develop novel therapeutic targets. Critical components of successful responses to this program announcement are (1) preclinical or early clinical testing of promising new therapeutic strategies to terminate and prevent cardiac arrhythmias in established models of human arrhythmogenic disease, and (2) the feasibility to move positive findings to Phase l or ll clinical trials. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Federal Grant Title: Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-07-101
Type of Funding: Grant
CFDA Numbers: 93.837
CFDA Descriptions: Heart and Vascular Diseases Research
Current Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Dec 01, 2006
Creation Date: Dec 05, 2008
Archive Date: Oct 02, 2009
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not...
Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...
Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...
ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial No...
The Relationship Between Hypertension and Inflammation
Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and A...
Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01)
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com